Novo Nordisk (NVO) Stock Rockets 6% Following FDA’s Compounding Pharmacy Crackdown

Novo Nordisk (NVO) stock surged over 6% after FDA proposed removing weight-loss drugs from compounding list, hitting highest level in two months.

The post Novo Nordisk (NVO) Stock Rockets 6% Following FDA’s Compounding Pharmacy Crackdown appeared first on Blockonomi.